Got a tip?:

Posts Tagged ‘INSYS’

FDA Grants INSYS Therapeutics’ Fast Track Designation for Epinephrine Nasal Spray

Arizona-based specialty pharmaceutical company INSYS Therapeutics saw its shares explode after announcing that the Food and Drug Administration has granted its epinephrine nasal spray fast track designation. The FDA has granted the company’s epinephrine nasal spray fast track designation as an investigational treatment for anaphylaxis. Anaphylaxis is a severe, potentially life-threatening allergic reaction. It can…

Read More